Our findings that the stimulatory effects of DLX4 on VEGF-A production and tumor angiogenesis are abrogated when iNOS is inhibited support the conclusion that these stimulatory effects of DLX4 are primarily mediated via its induction of iNOS. The gene discussed is NOS2; the disease is neoplasm.